Cart
sales@molnova.com
Oxynitidine
CAS No. 548-31-2
Oxynitidine( ——— )
Catalog No. M38115 CAS No. 548-31-2
Oxynitidine is an HBV inhibitor (ID50=30.8 μg/mL), which can effectively inhibit the DNA replication activity of HBV. Oxynitidine can be used in the study of viral infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOxynitidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxynitidine is an HBV inhibitor (ID50=30.8 μg/mL), which can effectively inhibit the DNA replication activity of HBV. Oxynitidine can be used in the study of viral infections.
-
DescriptionOxynitidine is an HBV inhibitor (ID50=30.8 μg/mL), which can effectively inhibit the DNA replication activity of HBV.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number548-31-2
-
Formula Weight363.36
-
Molecular FormulaC21H17NO5
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chin-Teng Chang, et al. Coumarins and anti-HBV constituents from Zanthoxylum schinifolium.
molnova catalog
related products
-
Acetylcimigenol 3-O-...
Acetylshengmanol Arabinoside is isolated from Cimicifugae rhizoma.
-
Ly-295501
Ly-295501 (ILX-295501) showed antitumor and anticancer activity in human pancreatic cancer xenotransplantation model.
-
(Asp76)-pTH (39-84) ...
(Asp76)-pTH (39-84) (human) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
